Janus Biotherapeutics Lands Partial VC Funding
Monday, August 22, 2011 5:31:00 AM PDT | VentureDeal Staff
Wellesley, Massachusetts -- Stealth biotechnology company Janus Biotherapeutics (no website) has received $1.1 million in new venture capital investment, according to an SEC regulatory filing.
Janus says that it is focused on "progressing a series of small molecule leads for the treatment of autoimmune diseases."
Investors in the financing were not disclosed. The company is still seeking an additional $1.9 million in financing.
Email Page | Print Page